Role of angiogenesis after muscle derived stem cell transplantation in injured medial collateral ligament

Journal of Orthopaedic Research

Volumn 30, Issue 4, 2012, Pages 627-633

  Nishimori, Makoto ^a,b   Matsumoto, Tomoyuki ^a   Ota, Shusuke ^a   Kopf, Sebastian ^a   Mifune, Yutaka ^a   Harner, Christopher ^b,c   Ochi, Mitsuo ^d   Fu, Freddie H ^b   Huard, Johnny ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

angiogenesis; medial collateral ligament (MCL); muscle derived stem cells (MDSCs); soluble fms like tyrosine kinase 1 (sFLT1; vascular endothelial growth factor (VEGF); VEGF antagonist)

Indexed keywords

BETA GALACTOSIDASE; CD135 ANTIGEN; ISOLECTIN B4; PHOSPHATE BUFFERED SALINE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; CAPILLARY DENSITY; CONTROLLED STUDY; FEMALE; HEALING; IMMUNOHISTOCHEMISTRY; KNEE LIGAMENT INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; BIOMECHANICS; CELLS, CULTURED; FEMALE; KNEE INJURIES; LAC OPERON; MEDIAL COLLATERAL LIGAMENT, KNEE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; WOUND HEALING;

EID: 84857033065     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21551     Document Type: Article

References (44)

1. Peterson L, Junge A, Chomiak J, et al. 2000. Incidence of football injuries and complaints in different age groups and skill-level groups. Am J Sports Med 28: S51-S57.
2. Najibi S, Albright JP,. 2005. The use of knee braces, part 1: prophylactic knee braces in contact sports. Am J Sports Med 33: 602-611. (Pubitemid 40411169)
3. Bray RC, Leonard CA, Salo PT,. 2003. Correlation of healing capacity with vascular response in the anterior cruciate and medial collateral ligaments of the rabbit. J Orthop Res 21: 1118-1123. (Pubitemid 37322394)
4. Woo SL, Vogrin TM, Abramowitch SD,. 2000. Healing and repair of ligament injuries in the knee. J Am Acad Orthop Surg 8: 364-372.
5. Miyamoto RG, Bosco JA, Sherman OH,. 2009. Treatment of medial collateral ligament injuries. J Am Acad Orthop Surg 17: 152-161.
6. Becker R, Pufe T, Kulow S, et al. 2004. Expression of vascular endothelial growth factor during healing of the meniscus in a rabbit model. J Bone Joint Surg Br 86: 1082-1087. (Pubitemid 39255881)
7. Pufe T, Paulsen F, Petersen W, et al. 2003. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. J Pathol 200: 130-136. (Pubitemid 36592646)
8. Pufe T, Petersen W, Tillmann B, et al. 2001. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 28: 1482-1485. (Pubitemid 32660616)
9. Nakamura N, Shino K, Natsuume T, et al. 1998. Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament. Gene Ther 5: 1165-1170. (Pubitemid 28448423)
10. Schmidmaier G, Wildemann B, Ostapowicz D, et al. 2004. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors. J Orthop Res 22: 514-519. (Pubitemid 38489727)
11. Yoshikawa T, Tohyama H, Katsura T, et al. 2006. Effects of local administration of vascular endothelial growth factor on mechanical characteristics of the semitendinosus tendon graft after anterior cruciate ligament reconstruction in sheep. Am J Sports Med 34: 1918-1925. (Pubitemid 44704245)
12. Bohle AS, Kalthoff H,. 1999. Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 384: 133-140. (Pubitemid 29227304)
13. Docheva D, Hunziker EB, Fassler R, et al. 2005. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25: 699-705. (Pubitemid 40096590)
14. Corral CJ, Siddiqui A, Wu L, et al. 1999. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 134: 200-205. (Pubitemid 29088975)
15. Phillips GD, Stone AM, Jones BD, et al. 1994. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 8: 961-965.
16. Cao B, Zheng B, Jankowski RJ, et al. 2003. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 5: 640-646. (Pubitemid 36818086)
17. Lee JY, Qu-Petersen Z, Cao B, et al. 2000. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150: 1085-1100.
18. Qu-Petersen Z, Deasy B, Jankowski R, et al. 2002. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157: 851-864. (Pubitemid 34847822)
19. Peng H, Wright V, Usas A, et al. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751-759.
20. Peng H, Usas A, Gearhart B, et al. 2004. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. J Bone Miner Res 19: 630-641. (Pubitemid 41071224)
21. Payne TR, Oshima H, Okada M, et al. 2007. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50: 1677-1684. (Pubitemid 47562673)
22. Deasy BM, Feduska JM, Payne TR, et al. 2009. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther 17: 1788-1798.
23. Matsumoto T, Cooper GM, Gharaibeh B, et al. 2009. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 60: 1390-1405.
24. Gharaibeh B, Lu A, Tebbets J, et al. 2008. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 3: 1501-1509.
25. van Deutekom JC, Floyd SS, Booth DK, et al. 1998. Implications of maturation for viral gene delivery to skeletal muscle. Neuromuscul Disord 8: 135-148. (Pubitemid 28246108)
26. Tei K, Matsumoto T, Mifune Y, et al. 2008. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells 26: 819-830.
27. Watanabe N, Woo SL, Papageorgiou C, et al. 2002. Fate of donor bone marrow cells in medial collateral ligament after simulated autologous transplantation. Microsc Res Tech 58: 39-44. (Pubitemid 34701139)
28. Kawamoto A, Gwon HC, Iwaguro H, et al. 2001. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637. (Pubitemid 32144189)
29. Canale ST, Cantler ED Jr., Sisk TD, et al. 1981. A chronicle of injuries of an American intercollegiate football team. Am J Sports Med 9: 384-389. (Pubitemid 12163475)
30. Fukushima K, Badlani N, Usas A, et al. 2001. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29: 394-402. (Pubitemid 32661352)
31. Nozaki M, Li Y, Zhu J, et al. 2008. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 36: 2354-2362.
32. Shukunami C, Oshima Y, Hiraki Y,. 2005. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 333: 299-307. (Pubitemid 40848292)
33. Shukunami C, Takimoto A, Oro M, et al. 2006. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 298: 234-247. (Pubitemid 44414808)
34. Day CS, Kasemkijwattana C, Menetrey J, et al. 1997. Myoblast-mediated gene transfer to the joint. J Orthop Res 15: 894-903. (Pubitemid 28121504)
35. Kanaya A, Deie M, Adachi N, et al. 2007. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy 23: 610-617. (Pubitemid 46873895)
36. Batten ML, Hansen JC, Dahners LE,. 1996. Influence of dosage and timing of application of platelet-derived growth factor on early healing of the rat medial collateral ligament. J Orthop Res 14: 736-741. (Pubitemid 26376517)
37. Provenzano PP, Alejandro-Osorio AL, Grorud KW, et al. 2007. Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments. BMC Physiol 7: 2.
38. Meller R, Brandes G, Drogemuller C, et al. 2009. Graft remodeling during growth following anterior cruciate ligament reconstruction in skeletally immature sheep. Arch Orthop Trauma Surg 129: 1037-1046.
39. Nakamura K, Kitaoka K, Tomita K,. 2008. Effect of eccentric exercise on the healing process of injured patellar tendon in rats. J Orthop Sci 13: 371-378.
40. Petersen W, Unterhauser F, Pufe T, et al. 2003. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep. Arch Orthop Trauma Surg 123: 168-174. (Pubitemid 36747764)
41. Ju YJ, Tohyama H, Kondo E, et al. 2006. Effects of local administration of vascular endothelial growth factor on properties of the in situ frozen-thawed anterior cruciate ligament in rabbits. Am J Sports Med 34: 84-91. (Pubitemid 43038233)
42. Molloy T, Wang Y, Murrell G,. 2003. The roles of growth factors in tendon and ligament healing. Sports Med 33: 381-394. (Pubitemid 36560710)
43. Chamberlain CS, Crowley E, Vanderby R,. 2009. The spatio-temporal dynamics of ligament healing. Wound Repair Regen 17: 206-215.
44. Gharaibeh B, Lavasani M, Cummins JH, et al. 2011. Terminal differentiation is not a major determinant for the success of stem cell therapy-cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther 2: 31.